"Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high‐purity plasma‐derived factor X (pdFX) concentrate"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high‐purity plasma‐derived factor X (pdFX) concentrate

Hereditary factor X (FX) deficiency (FXD) affects 1:500 000‐1:1 000 000 people worldwide. A novel, high‐purity plasma‐derived FX concentrate (pdFX) is available in the United States and European Union as… Click to show full abstract

Keywords: fxd; hereditary factor; deficiency fxd; pdfx; factor; factor deficiency

Journal Title: Haemophilia
Year Published: 2018

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended